← FDA Drug Approvals (Drugs@FDA)

DALVANCE

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2014-05-23

Drug application

FDA Application #

NDA021883

Application type

New Drug Application

Brand name

DALVANCE

Generic name

DALBAVANCIN

Active ingredients

DALBAVANCIN HYDROCHLORIDE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2014-05-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown